Tower Research Capital LLC (Trc) Talaris Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.68 - $3.22 $2,578 - $3,097	962 New	962 $2,000
Q1 2023 May 09, 2023	SELL	$1.09 - $2.09 $401 - $769	-368 Reduced 4.07%	8,666 $16,000
Q4 2022 Feb 10, 2023	BUY	$0.94 - $1.64 $373 - $651	397 Added 4.6%	9,034 $9,000
Q3 2022 Nov 10, 2022	BUY	$2.3 - $5.03 $12,116 - $26,498	5,268 Added 156.37%	8,637 $23,000
Q2 2022 Aug 15, 2022	SELL	$4.51 - $9.85 $20,944 - $45,743	-4,644 Reduced 57.96%	3,369 $15,000
Q1 2022 May 12, 2022	BUY	$6.89 - $16.56 $50,331 - $120,970	7,305 Added 1031.78%	8,013 $79,000
Q4 2021 Feb 14, 2022	SELL	$12.18 - $17.0 $937 - $1,309	-77 Reduced 9.81%	708 $11,000
Q3 2021 Nov 15, 2021	BUY	$11.61 - $15.99 $8,394 - $11,560	723 Added 1166.13%	785 $10,000
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $759 - $1,153	62 New	62 $1,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.